Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state

Journal of Virological Methods

Volumn 159, Issue 2, 2009, Pages 300-302

  Sener, Asli Gamze ^a   Afsar, Ilhan ^a   Pinar, Ercan ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Antibody; Avidity; Epstein Barr virus; Immunoblot

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; EPSTEIN BARR VIRUS; GROUPS BY AGE; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SERODIAGNOSIS; VIRUS INFECTION; VIRUS REACTIVATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIGENS, VIRAL; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HUMAN HERPESVIRUS 4;

EID: 66049104208     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.04.009     Document Type: Article

References (16)

1. Bauer G. Rationale und rationelle EBV-diagnostik. Clin. Lab. 41 (1995) 623-634
2. Bauer G. Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Clin. Lab. 47 (2001) 223-230
3. Bruu A.L., Hjetland R., Holter E., Mortensen L., Natas O., Petterson W., Skar A.G., Skarpaas T., Tjade T., and Åsjø B. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin. Diagn. Lab. Immunol. 7 (2000) 451-456
4. Gartner B.C., Hess R.D., Bandt D., Kruse A., Erstwhile A., Roemer K., and Mueller-Lantzsch N. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin. Diagn. Lab. Immunol. 10 (2003) 78-82
5. Harada S., Kamata, Ishii Y.Y., Eda H., Kitamura R., Obayashi M., Ito S., Fumihiko Ban F., Kuranari J., Nakajima H., Kuze T., Hayashi M., Okabe N., Senpuku H., Miyasaka N., Nakamura Y., Kanegane H., and Yanagi K. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr Virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection. Clin. Diagn. Lab. Immunol. 11 (2004) 123-130
6. Hess R.D. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J. Clin. Microbiol. 42 (2004) 3381-3387
7. Nystad T.W., and Myrmel H. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. J. Clin. Virol. 38 (2007) 292-297
8. Obel N., Høier-Madsen M., and Kangro H. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS 104 (1996) 424-428
9. Ooka T., de Turenne-Tessier M., and Stolzenberg M.C. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Springer Semin. Immunopathol. 13 (1991) 233-247
10. Paschale M.D., Agrappi C., Manco M.T., Miri P., Vigano E.D., and Clerici P. Seroepidemiology of EBV and Interpretation of the "Isolated VCA IgG" Pattern. J. Med. Virol. 81 (2009) 325-331
11. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Knipe D.M., Howley P.M., Griffin D.E., Martin M.A., Lamb R.A., and Roizman B. (Eds). Fields Virology. 4th ed. (2001), Lippincott Williams & Wilkins, Philadelphia, PA 2575-2627
12. Robertson P., Beynon S., Whybin R., Brennan C., Vollmer-Conna U., Hickie I., and Lloyd A. Measurement of EBV-IgG Anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. J. Med. Virol. 70 (2003) 617-623
13. Schubert J., Zens W., and Weissbrich B. Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections. J. Clin. Virol. 11 (1998) 161-172
14. Takeuchi K., Tanaka-Taya K., Kazuyama Y., Ito Y.M., Hashimoto S., Fukayama M., and Mori S. Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol. Int. 56 (2006) 112-116
15. Wolter T., Gassmann C., Vetter V., and Bauer G. Avidity determination: utilization of a basic immunological mechanism allows improvement of the serodiagnosis of infections. Clin. Lab. 43 (1997) 125-135
16. Zeytinoglu A., Altuglu I., Karatas E., and Yazan Sertoz R. Comparison of immunofluorescence assay and multiplexed microparticle-based immunoassay for detecting Epstein-Barr virus viral capsid antigen antibodies. J. Virol. Methods 148 (2008) 300-302